Pandemic's "rough stretch" made it tough to keep private practice doors open, advocate says
Nearly three-fourths of U.S. physicians opted for employment with hospitals, health systems, or other corporate entities, such as private equity firms and health insurers in the pandemic era, according to a new report.
In 2021, 73.9% of physicians were hospital- or corporate-employed, up from 69.3% at the start of 2021, 64.5% at the start of 2020, and 62.2% at the start of 2019, according to the nonprofit Physicians Advocacy Institute (PAI) and consulting firm Avalere. That equates to 484,100 employed physicians, up from 423,800, 391,000, and 375,400 at the start of 2021, 2020, and 2019, respectively.
Overall, 108,700 physicians shifted to employment since January 2019, and that growth was split about evenly between hospital employees (n=58,200) and those within other corporate entities (n=50,500). Notably, of those physicians, 76% (n=83,000) did so since the pandemic began.
|
|
|
|
ASIPP 24th Annual Meeting
May 5-7, 2022 | Las Vegas, Nevada
|
|
24 YEARS & COUNTING!
Focusing on Fundamentals to Build the Future of IPM
Discussion on health policy with three prominent members of congress:
- The Honorable Ed Whitfield
- The Honorable Larry Buschon
- The Honorable James Comer
Raj/Racz Distinguished Lectures:
- Neuromodulation
- Documentation of medical necessity to perform epidural and facet joint intervention LCDs and evaluation and management services
Multiple General Session Topics:
- Various types of solutions in epidural injections
Keynote speech by Harsha Shanthanna, MD
- Facet joint interventions
- The opioid/illicit drug epidemic
- Compassionate prescribing
|
|
National Physician Employment Trends
Over the three-year study period ending in 2021, 108,700 additional physicians left independent practice and became employees of hospitals or other corporate entities, and 83,000 (76%) of that growth occurred after the onset of Covid-19.
- 58,200 additional physicians became hospital employees between 2019-21 o 51,000 of that growth occurred after the onset of Covid-19
- 50,500 additional physicians became employees of corporate entities between 2019- 21
- 32,000 of that growth occurred after the onset of Covid-19 By the end of 2021, nearly three of four (74%) of physicians were employed by hospitals, health systems or corporate entities such as private equity firms or health insurers.
- 52.1% of physicians were employed by hospitals and health systems
- 21.8% of physicians were employed by other types of corporate entities
|
|
NEXT EXAM DATES:
Part I
May 28, June 18, July 30, August 27, September 17, October 22, November 19 & December 17
Part II
July 15 & September 23
|
|
Overdoses are increasing at a troubling rate.
Sean Blake was among those who died. He overdosed at age 27 in Vermont, from a mix of alcohol and fentanyl, a synthetic opioid. He had struggled to find effective treatment for his addiction and other potential mental health problems, repeatedly relapsing.
“I do love being sober,” Blake wrote in 2014, three years before his death. “It’s life that gets in the way.”
|
|
"A lot of it boils down to a lack of patient and provider familiarity with the medication"
Access to Paxlovid, the first oral antiviral treatment for COVID-19, has expanded since the FDA issued an emergency use authorization (EUA) for the Pfizer-made medication in December. However, physicians and pharmacists say there is still more that can be done to make sure the potentially life-saving drug reaches the right people at the right time.
Paxlovid is currently authorized for adults and children ages 12 and older who have tested positive for COVID and are at high risk for severe outcomes, including hospitalization and death. A clinical trial supporting the EUA showed that the drug reduced hospitalizations and death by 88%.
Of note, Paxlovid must be initiated within 5 days of symptom onset, meaning that not only do patients and providers need to be aware of the drug's availability, they also need to know how to quickly and conveniently get it.
|
|
- ASIPP Members Only Site Information -
|
|
-
To log in for the first time you will need to click “forgot password” at the bottom of the login window.
- Check your email and then log in as directed.
-
If you have problems logging into your account, click here.
|
|
Pain Medicine Case Reports (PMCR) and Editor-in-Chief Alaa Abd-Elsayed, MD, PhD would like to invite you to submit case reports and case series to the PMCR journal. Your article will be published free of charge.
Open access journals are freely available online for immediate worldwide open access to the full text of published articles. There is no subscription fee for open access journals. Open access journals are no different from traditional subscription-based journals: they undergo the same peer-review and quality control as any other scholarly journal.
Interested in becoming a member of the PMCR Editorial Board?
Editorial board members are asked to review 2-6 manuscripts per year. Please submit your most up-to-date CV to sgold@asipp.org for consideration.
For more information or to submit your articles, click here.
|
|
| CASE REPORT |
Jillian Maloney, MD, Christopher Wie, MD, Audrey Keim, BS, and Natalie Strand, MD
Abstract
BACKGROUND: Stress-induced cardiomyopathy (SIC), also known as Takotsubo cardiomyopathy, resembles myocardial infarction with transient regional wall-motion abnormalities of the left ventricle and is often associated with physical or emotional stress. Unlike myocardial infarction, coronary angiography reveals no significant evidence of coronary artery disease or plaque rupture. The pathogenesis of SIC remains unclear, but it is proposed to be related to increased catecholamine release causing cardiotoxicity.
CASE REPORT: An 85-year-old woman presented with dizziness, nausea, and weakness immediately after an attempted trigger-point injection procedure. She was later found to have elevated cardiac markers and a negative coronary angiogram, and was subsequently diagnosed with SIC.
CONCLUSIONS: Increased awareness of SIC during common medical procedures may improve its recognition and underscore the importance of managing patients’ procedural stress.
KEY WORDS: Stress-induced cardiomyopathy, trigger point injection, procedural anxiety
|
|
| NARRATIVE REVIEW |
Morgan E. Gonder, MD, Walter N. Orr, MPH, and Talal W. Khan, MD
Abstract
Background: During the COVID-19 pandemic, social distancing has been employed to decrease the spread of COVID-19, especially within the geriatric population; however, the resulting loneliness and isolation carry their own detrimental effects. Loneliness resulting from the COVID-19 pandemic may also have negative implications on those with chronic musculoskeletal pain.
Objectives: The aim of this review was to identify the role of loneliness specific to the recent COVID-19 pandemic as it relates to the prevalence and severity of chronic pain in the geriatric population and to provide an overview for clinicians.
Study design: Narrative review.
Methods: A literature search was conducted using combinations of relevant search terms. Databases included PubMed and relevant grey literature sources. Reference lists of selected articles were also searched for additional relevant literature.
Results: Recent literature supports that social isolation and loneliness stemming from the COVID-19 pandemic have negative implications on chronic musculoskeletal pain. Loneliness has been well documented to have deleterious effects on physical and mental health, and it is increasingly linked to worsening debility and pain interference for those with chronic musculoskeletal pain. This has been found to be most prominent in the geriatric population, who are at the greatest risk for social decline and loneliness. Loneliness has also been found to have negative effects on cardiovascular disease, infectious disease, and mental health, as well as cognitive decline.
Limitations: Potential selection bias due to the narrative review design. Some included studies required the use of online questionnaires, which may not be accessible for the geriatric population, those without technology literacy, or low socioeconomic status populations. Future studies should emphasize screening patients for access to technological devices and reliable internet while partnering with community programs focused on digital literacy and resource access.
Conclusions: A myriad of deleterious effects stemming from social isolation and loneliness have been documented, of which geriatric populations are especially susceptible. Both early identification of at-risk patients and safe interventions are essential to mitigate loneliness and stop the progression of debility. Further resources and research are necessary to illuminate how best to proceed, both in the setting of the ongoing pandemic and how interventions can be applied to alleviate suffering in those with limited ability to receive hospital or clinic-based care.
Keywords: COVID-19 pandemic; geriatric; loneliness; mental health; musculoskeletal pain; pain medicine; social isolation; Chronic pain.
|
|
| LITERATURE REVIEW |
Ruben H. Schwartz, DO, Stephanie Hernandez, MD, Nazir Noor, MD, Jacob Topfer, DO, Kyle Farrell, MD, Naina Singh, MS, Ayushi Sharma, MS, Giustino Varrassi, MD, PhD, and Alan D. Kaye, MD, PhD
Abstract
Background: Spinal Anesthesia was the first regional anesthetic technique to be performed. It was performed by Dr. August Bier, known for the Bier block, and his colleagues on August 16, 1898. Dr. Bier opted for, what he referred to at the time as "cocainization of the spinal cord" by introducing 15 mg of cocaine intrathecally prior to the operation. The surgery was largely uneventful and painless. The patient only experienced some vomiting and a headache postoperatively. Dr. Bier's use of neuraxial anesthesia aimed to directly inject local anesthetics in and around the central nervous system (CNS) for more direct control of pain and anesthesia. Local anesthetics were an important discovery in anesthesiology. However, since the advent of local anesthetics and spinal anesthesia as an alternative technique to general anesthesia, much has been learned about both the benefits and adverse effects of local anesthetics. It was quickly learned that use of local anesthetics would be limited by their potential for life-threatening toxic effects. For this reason, there was a push towards development of novel local anesthetics that had a larger therapeutic window with less likelihood of serious side effects. In addition to developing newer local anesthetics, the idea of adding adjuvants provided an opportunity to potentially limit the life-threatening events. These adjuvants would include medications such as epinephrine and alpha-2 agonists, such as clonidine and dexmedetomidine. Other adjuvants include opioids, glucocorticoids, and mineralocorticoids.
Objectives: In this review, we will delve further into the indications, contraindications, uses, mechanisms, and future of spinal anesthesia and its adjuvants.
Study design: A literature review of recent publications in the field of alpha 2 agonists used in spinal anesthetics was carried out from 2015 to present day. Consensus opinions were formulated in various areas.
Setting: This literature review was carried out at various medical universities throughout the nation and Europe.
Limitations: As research has only just begun in this field data is limited at this time.
Conclusions: The use of spinal anesthesia provides a reliable dermatome blockade to facilitate many different surgical procedures. The combination of local anesthetics with opioid medications within the subarachnoid space has been the standard of care. Adjuvant medications like alpha 2 agonists may play a significant role in prolonging spinal blockade as well as limiting cardiovascular complications such as hypotension and bradycardia. The use of alpha 2 agonists instead of opioid medications intrathecally decreases pruritus and delayed respiratory depression. Animal models have demonstrated the synergistic effects of utilizing alpha 2 agonists with opioids in the subarachnoid space. The addition of clonidine to fentanyl and local anesthetic demonstrated a shorter time to neural blockade, but no significant change in duration of the spinal. Interestingly alpha 2 agonists with local anesthetics showed increase block duration compared to opioid with local anesthetics. Further human trials need to be undertaken to analyze the effectiveness of alpha 2 agonists in the intrathecal space, but preliminary data does indicate it is an exemplary alternative to opioids.
Keywords: obstetrics; spinal anesthetics; Alpha 2 agonist.
|
|
Since this malpractice insurance program officially launched in November 2018, ASIPP has signed up hundreds of providers with an average savings of 30%. This is professional liability insurance tailored to our specialty and will stand up for us and defend our practices.
Norcal Mutual is A-Rated by AM best and is licensed in all 50 states. To read a few important points to keep in mind about the program, including discounts, administrative defense, cyber coverage, aggressive claims handling, and complimentary award-winning risk management CME activities, click here.
|
|
ASIPP® has formed a partnership with Henry Schein and PedsPal, a national GPO that has a successful history of negotiating better prices on medical supplies and creating value-added services for independent physicians. Working with MedAssets, PedsPal provides excellent pricing on products like contrast media that alleviate some of the financial pressures you experience today.
|
|
ASIPP® is now offering our members the benefit of a unique revenue cycle management/ billing service.
We have received a tremendous amount of interest in the ASIPP® billing and coding program.
Click here to learn more about the negotiated rate for practices and more!
|
|
|
up-to-date news related to you, your practice, and your patients!
|
|
|
|
|
|
|